Mechanism of Action: Triprolidine is a first generation H1-antagonist that competes with histamine for binding at H1-receptor sites to lessen symptoms caused by histamine release. H1-antagonists also produce anticholinergic effects through antagonism of neuronal and neuromuscular muscarinic receptors. First generation antihistamines do cross the blood-brain barrier to bind to receptors in the central nervous system.